COVID-19: NAFDAC Receives Dossiers For Chinese Vaccine, Others For Evaluation – Minister
The National Agency for Food and Drug Administration and Control (NAFDAC) has received dossiers for Chinese vaccine and three others ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has received dossiers for Chinese vaccine and three others ...
The Lagos State Government has sealed over 14 facilities including event centres, night clubs among others for violating a curfew ...
Bayern Munich forward Thomas Mueller is set to miss out on Thursday’s Club World Cup final in Doha after testing ...
Zimbabwe will receive 800,000 coronavirus vaccine doses developed by China’s Sinopharm by the start of March, the government has said ...
The Lagos state government on Thursday warned protesters planning to converge at the Lekki toll gate on Saturday to desist ...
German Covid-19 vaccine maker BioNTech said Wednesday it has started production at its new facility in Marburg, expected to significantly ...
Queen Elizabeth II’s eldest son and heir Prince Charles, who contracted Covid-19 last year, has received a first vaccine dose, ...
Travellers arriving in Britain from abroad will have to take two coronavirus tests during quarantine, the government is expected to ...
Greece is facing a third coronavirus wave, the health minister said on Tuesday as officials met to discuss tighter lockdown ...
When doctor Andreas Bootsveld has to make life-or-death decisions about Covid-19 patients, he is not alone — as well as ...
Eagle Eyes News (a subsidiary company of Eagle Eyes Communications) is a contemporary news platform which prides itself as the one-stop shop for breaking news. Eagle Eyes seeks to inform the public and disseminate news around the world, ranging from politics, local news, sports, entertainment, business, etc…
Read more
Be an Eagle Eyes News Reporter. Share what’s happening around you and let us project it for the World to see and read. Send details to info@eagleeyesnews.ng
You can also chat +2340808 493 5133
© 2023 Eagleeyes News, A subsidiary of Eagle Eyes Communications Ltd. | All Rights Reserved
© 2023 Eagleeyes News, A subsidiary of Eagle Eyes Communications Ltd. | All Rights Reserved